期刊文献+

过表达Vav1蛋白对乳腺癌细胞系T47D细胞增殖的影响

Effects of Vav1Overexpression on Cell Proliferation in Human Breast Cancer Cell Line T47D
原文传递
导出
摘要 Vav1是造血系统中的重要蛋白,具有鸟苷酸交换因子(guanine nucleotide exchange factor,GEF)活性,能够催化Rac/Rho GTP酶的活性,从而参与众多的细胞事件,如细胞骨架重组,基因的转录,免疫细胞的发育和活化,细胞增殖和凋亡等.近年来,在包括乳腺癌在内的人类癌症中均发现有Vav1的表达,但对于Vav1在乳腺癌细胞中的具体功能和机制仍不清楚.本研究中,通过慢病毒包装系统感染乳腺癌细胞系T47D构建了稳定表达Vav1的乳腺癌细胞系,通过WST-1检测细胞增殖和细胞流式法检测细胞周期发现Vav1能够促进细胞增殖,同时通过蛋白免疫印迹技术和报告基因系统发现这一过程可能跟Vav1增强转录因子NF-κB转录活性上调细胞周期相关蛋白Cyclin D1相关. Vavl, a guanine nucleotide exchange factor (GEF) for Rho family GTPases, is hematopoietic protein involved in a variety of cellular events. In recent years, Vavl has been reported to aberrantly express in several human malignancies including human breast cancer. But the specific function and mechanisms of Vavl in breast cancer is not clear. In this study, a stable line expressing Vavl was established with lentivirus system in human breast cancer cell line T47D. Function studies indicated Vavl overexpression might increase NF-rB tran- scription to up-regulated cell cycle-related protein, Cyclin D1, and consequently enhance cell proliferation in T47D cells. The results suggested ectopic expression of Vavl in breast cancer may play a significant role in tu- morigenesis.
出处 《南开大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第4期37-42,共6页 Acta Scientiarum Naturalium Universitatis Nankaiensis
关键词 乳腺癌 T47D 细胞增殖 CYCLIN D1 NF-ΚB human breast cancer T47D cell proliferation Cyclin DI NF-kB
  • 相关文献

参考文献1

二级参考文献42

  • 1Katzav S, Martin-Zanca D, Barbacid M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 1989; 8: 2283-90.
  • 2Movilla N, Bustelo XR. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol 1999; 19: 7870-85.
  • 3Schuebel KE, Bustelo XR, Nielsen DA, Song B J, Barbacid M, Goldman D, et al. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Oncogene 1996; 13: 363-71.
  • 4Fischer KD, Zmuldzinas A, Gardner S, Barbacid M, Bernstein A, Guidos C. Defective T-cell receptor signalling and positive selection of Vav-deficient CD^4+ CD^8+ thymocytes. Nature 1995; 374: 474-7.
  • 5Turner M, Mee PJ, Waiters AE, Quinn ME, Mellor AL, Zamoyska R, et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 1997; 7: 451-60.
  • 6Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, et al. Vavl/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 2003; 198: 1595-608.
  • 7Cao Y, Janssen EM, Duncan AW, Altman A, Billadeau DD, Abraham RT. Pleiotropic defects in TCR signaling in a Vav-l-null Jurkat T-cell line. EMBO J 2002; 21: 4809-19.
  • 8Paccani SR, Boncristiano M, Patrussi L, Ulivieri C, Wack A, Valensin S, et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 2005; 106: 626-34.
  • 9Prieto-Sanchez RM, Hernandez JA, Garcia JL, Gutierrez NC, San M J, Bustelo XR, et al. Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q. Br J Haematol 2006; 133: 642-5.
  • 10Homstein I, Pikarsky E, Groysman M, Amir G, Peylan-Ramu N, Katzav S. The haematopoietic specific signal transducer Vavl is expressed in a subset of human neurobiastomas. J Pathol 2003; 199: 526-33.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部